CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma.

Abstract:

:Cell differentiation agent-2 (CDA-2) is an extraction from healthy human urine consisting of primary organic acids and peptides, and it has been demonstrated to inhibit growth and induce differentiation in glioma and other cell lines. But the mechanism of CDA-2 remains unclear. In this study, we demonstrated that CDA-2 inhibited cell growth and induced differentiation of glioma cells, accompanied with decreased expression of SLUG, Twist and Vimentin in both SWO-38 and U251 cell lines. Overexpression of SLUG or Twist greatly eliminated the efficiency of CDA-2 in inducing differentiation. Further study showed that CDA-2 treatment resulted in great changed microRNAs (miRNAs) detected by quantitative PCR, in which miR-124 was one of the most changed miRNAs and its level was increased by fourfold. The result of miRNA target prediction showed that miR-124 could regulate hundreds of genes which were relative to cell differentiation, such as SLUG, Vimentin, actin cytoskeleton, focal adhesion, tight junction. Inhibition of miR-124 up-regulated SLUG, Twist and Vimentin proteins, and partly eliminated the function of CDA-2 on these mesenchymal markers. Our findings demonstrated for the first time that CDA-2 induced cell differentiation through suppressing Twist and SLUG via miR-124 in glioma cells.

journal_name

J Neurooncol

authors

Xie YK,Huo SF,Zhang G,Zhang F,Lian ZP,Tang XL,Jin C

doi

10.1007/s11060-012-0961-x

subject

Has Abstract

pub_date

2012-11-01 00:00:00

pages

179-86

issue

2

eissn

0167-594X

issn

1573-7373

journal_volume

110

pub_type

杂志文章
  • Extramedullary hematopoiesis within the clivus: an unusual cause of lower cranial nerve palsy.

    abstract::We report one year follow up of a case of extramedullary hematopoiesis within the clivus. The imaging findings, brief clinical course, and endoscopic transphenoidal approach are described. A 29-year-old female with thalassemia developed worsening cranial nerve signs. After imaging studies discovered a large clival mas...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-010-0208-7

    authors: Reames DL,Lindstrom K,Raghavan P,Jane J Jr

    更新日期:2010-12-01 00:00:00

  • Delay in radiotherapy shortens survival in patients with high grade glioma.

    abstract::Fractionated external beam radiotherapy is an important component of standard treatment for high grade glioma. Due to resource constraints, patients may experience delays in receiving treatment. The purpose of this study was to evaluate the effect of radiotherapy waiting time on survival in patients with high grade gl...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-007-9426-z

    authors: Irwin C,Hunn M,Purdie G,Hamilton D

    更新日期:2007-12-01 00:00:00

  • Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.

    abstract::We characterized health-related quality of life (HRQoL), cognitive, and functional status in newly diagnosed glioblastoma (GBM) patients receiving Tumor treating fields (TTFields) with temozolomide (TMZ) versus TMZ alone in a planned interim analysis of a randomized phase III trial [NCT00916409], which showed signific...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s11060-017-2601-y

    authors: Zhu JJ,Demireva P,Kanner AA,Pannullo S,Mehdorn M,Avgeropoulos N,Salmaggi A,Silvani A,Goldlust S,David C,Benouaich-Amiel A,Zvi Ram on behalf of the EF-14 Trial Investigators.

    更新日期:2017-12-01 00:00:00

  • Heregulins and the ErbB-2/3/4 receptors in gliomas.

    abstract::The activation of autocrine loops involving proto-oncogene related receptor tyrosine kinases has led to the analysis of a large number of growth factor systems in human glioma specimens and cell lines. The ErbB-2 system, also called HER-2 or neu, is analogous to the epidermal growth factor receptor system (EGF-R, ErbB...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1005837122181

    authors: Westphal M,Meima L,Szonyi E,Lofgren J,Meissner H,Hamel W,Nikolics K,Sliwkowski MX

    更新日期:1997-12-01 00:00:00

  • Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgery.

    abstract::Since its description in 1982, central neurocytoma (CN) has been a relatively innocuous rare tumor of the central nervous system. Comprising of less than 0.5% of all intracranial tumors, most are reported to be slow growing, with low recurrence rates, and a favorable prognosis. Because of its rarity, its cellular biol...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-010-0165-1

    authors: Tran H,Medina-Flores R,Cerilli LA,Phelps J,Lee FC,Wong G,Turner P

    更新日期:2010-11-01 00:00:00

  • Intracranial pseudolymphoma.

    abstract::Intracranial pseudolymphoma is a rare tumor of the central nervous system. A 35-year-old woman presented with a frontal subcutaneous tumor. Magnetic resonance imaging revealed a left frontal meningeal tumor involving subcutaneous tissue without bone involvement. The mass was completely removed and the histological asp...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1006414717891

    authors: Donnet A,Horschowski N,Dufour H,Figarella-Branger D,Bryon PA,Berger F,Harle JR,Grisoli F

    更新日期:2000-04-01 00:00:00

  • hHSS1: a novel secreted factor and suppressor of glioma growth located at chromosome 19q13.33.

    abstract::The completion of the Human Genome Project resulted in discovery of many unknown novel genes. This feat paved the way for the future development of novel therapeutics for the treatment of human disease based on novel biological functions and pathways. Towards this aim, we undertook a bioinformatics analysis of in-hous...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-010-0314-6

    authors: Junes-Gill KS,Gallaher TK,Gluzman-Poltorak Z,Miller JD,Wheeler CJ,Fan X,Basile LA

    更新日期:2011-04-01 00:00:00

  • Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases.

    abstract::Following surgical resection for brain metastases, fractionated stereotactic radiotherapy (FSRT) has been used as an alternative to single dose treatment for large cavities and to reduce risks of late toxicity. The purpose of this study was to evaluate the outcomes of patients treated with FSRT to the post-operative b...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-014-1417-2

    authors: Ahmed KA,Freilich JM,Abuodeh Y,Figura N,Patel N,Sarangkasiri S,Chinnaiyan P,Yu HH,Etame AB,Rao NG

    更新日期:2014-05-01 00:00:00

  • Inhibition of glioma cell proliferation by neural stem cell factor.

    abstract::Neural stem cells (NSC) have unique differentiation-, proliferation-, and motility properties. To investigate whether they secrete factors that interfere with the proliferation of glioma cells, we grew glioma cells in conditioned medium (CM) obtained from cultures of neurospheres including neural stem / progenitor cel...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-004-7118-5

    authors: Suzuki T,Izumoto S,Wada K,Fujimoto Y,Maruno M,Yamasaki M,Kanemura Y,Shimazaki T,Okano H,Yoshimine T

    更新日期:2005-09-01 00:00:00

  • Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience.

    abstract::In the following study, we present our experience in the treatment of PCNSL patients using a multi-step schedule combining chemotherapy and deferred radiotherapy. Patients were treated with two modified M-BACOD cycles and then differently according to radiological response For PR, SD and PD patients, chemotherapy was ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-006-9276-0

    authors: Silvani A,Salmaggi A,Eoli M,Lamperti E,Broggi G,Marras CE,Fariselli L,Milanesi I,Fiumani A,Gaviani P,Erbetta A,Giovagnoli AR,Pollo B,Botturi A,Boiardi A

    更新日期:2007-05-01 00:00:00

  • Alterations of cell cycle regulators in gliomatosis cerebri.

    abstract::Gliomatosis cerebri (GC) is regarded as a rare glial neoplasm of unknown origin, and a detailed analysis of molecular alterations underlying this disease has started only recently. However, because GC characteristically affects large parts of the brain and spinal cord, the distribution of genetic alterations may be hi...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-004-2061-z

    authors: Mawrin C,Kirches E,Schneider-Stock R,Boltze C,Vorwerk CK,von Mawrin A,Kirches E,Schneider-Stock R,Boltze C,Vorwerk CK,von Mawrin A,Kirches E,Schneider-Stock R,Boltze C,Vorwerk CK,von Mawrin A,Kirches E,Schneider-Stock R

    更新日期:2005-04-01 00:00:00

  • Evolution of a gene therapy clinical trial. From bench to bedside and back.

    abstract::Developing and conducting gene therapy clinical trials poses unique challenges which must be addressed to satisfy regulatory requirements and, most importantly, to protect human subjects. Experimental products used for gene transfer studies, such as viral vectors, are often complex and cannot be sterilized or complete...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1023/b:neon.0000003659.04633.6e

    authors: Aguilar LK,Aguilar-Cordova E

    更新日期:2003-12-01 00:00:00

  • Intramedullary non-Hodgkin's lymphoma of the spinal cord: a case report and literature review.

    abstract::We describe the case of a young man presenting with an extra-nodal, intramedullary non-Hodgkin's lymphoma of the cervical spinal cord. This is a very uncommon presentation of this neoplasm. The patient was treated with craniospinal radiotherapy, with survival for two and a half years before death from recurrent diseas...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF01059959

    authors: McDonald AC,Nicoll JA,Rampling R

    更新日期:1995-01-01 00:00:00

  • Inhibition of collagenolytic activity relates to quantitative reduction of invasion in vitro in a c-Ha-ras transfected glial cell line.

    abstract::The function of proteases in brain tumor invasion is currently not well established. For tumors of epithelial and fibromatous origin collagenase production can enhance the invasive capacity of cells to penetrate basement membranes. We showed previously that a c-Ha-ras transformed glial cell line (CxT24neo3) invaded ha...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF01052898

    authors: Boghaert ER,Chan SK,Zimmer C,Grobelny D,Galardy RE,Vanaman TC,Zimmer SG

    更新日期:1994-01-01 00:00:00

  • Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131.

    abstract::We report on the long-term results of a phase II study of pre-irradiation temozolomide followed by concurrent temozolomide and radiotherapy (RT) in patients with newly diagnosed anaplastic oligodendroglioma (AO) and mixed anaplastic oligoastrocytoma. Pre-RT temozolomide was given for up to 6 cycles. RT with concurrent...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s11060-015-1845-7

    authors: Vogelbaum MA,Hu C,Peereboom DM,Macdonald DR,Giannini C,Suh JH,Jenkins RB,Laack NN,Brachman DG,Shrieve DC,Souhami L,Mehta MP

    更新日期:2015-09-01 00:00:00

  • Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers.

    abstract::Combination of procarbazine, lomustine and vincristine (PCV) with radiation therapy (RT) has been associated with longer survival in patients with anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA), especially in those with chromosome 1p/19q codeletion. We report a multicenter retrospective study ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s11060-013-1288-y

    authors: Minniti G,Arcella A,Scaringi C,Lanzetta G,Di Stefano D,Scarpino S,Pace A,Giangaspero F,Osti MF,Enrici RM

    更新日期:2014-01-01 00:00:00

  • A radiotherapy technique to limit dose to neural progenitor cell niches without compromising tumor coverage.

    abstract::Radiation therapy (RT) for brain tumors is associated with neurocognitive toxicity which may be a result of damage to neural progenitor cells (NPCs). We present a novel technique to limit the radiation dose to NPC without compromising tumor coverage. A study was performed in mice to examine the rationale and another w...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-011-0530-8

    authors: Redmond KJ,Achanta P,Grossman SA,Armour M,Reyes J,Kleinberg L,Tryggestad E,Quinones-Hinojosa A,Ford EC

    更新日期:2011-09-01 00:00:00

  • Neuropsychological sequelae of the treatment of children with medulloblastoma.

    abstract::When a malignant tumor invades the child's cerebellum, the cost of successful treatment is often significant cognitive morbidity. A review of neuropsychological outcome revealed that survivors of childhood medulloblastoma (MB) have long-term deficits in intelligence, memory, language, attention, academic skills, psych...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00165522

    authors: Dennis M,Spiegler BJ,Hetherington CR,Greenberg ML

    更新日期:1996-07-01 00:00:00

  • Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.

    abstract::Ependymomas are glial neoplasms originating from the wall of the ventricles or from the spinal canal. The significance of histopathological features in accurately predicting biological behavior is still debated. Moreover, key molecular events in the pathogenesis of ependymoma are yet to be defined. The main objective ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-009-0039-6

    authors: Rousseau A,Idbaih A,Ducray F,Crinière E,Fèvre-Montange M,Jouvet A,Delattre JY

    更新日期:2010-05-01 00:00:00

  • Medical management of patients with brain tumors.

    abstract::The most common medical problems in brain tumor patients include the management of seizures, peritumoral edema, medication side effects, venous thromboembolism (VTE), fatigue and cognitive dysfunction. Despite their importance, there are relatively few studies specifically addressing these issues. There is increasing ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s11060-006-9193-2

    authors: Wen PY,Schiff D,Kesari S,Drappatz J,Gigas DC,Doherty L

    更新日期:2006-12-01 00:00:00

  • Transient cerebral hypoperfusion assisted intraarterial cationic liposome delivery to brain tissue.

    abstract::Transient cerebral hypoperfusion (TCH) has empirically been used to assist intraarterial (IA) drug delivery to brain tumors. Transient (<3 min) reduction of cerebral blood flow (CBF) occurs during many neuro- and cardiovascular interventions and has recently been used to better target IA drugs to brain tumors. In the ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-014-1421-6

    authors: Joshi S,Singh-Moon RP,Wang M,Chaudhuri DB,Holcomb M,Straubinger NL,Bruce JN,Bigio IJ,Straubinger RM

    更新日期:2014-05-01 00:00:00

  • Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging.

    abstract::The purpose of our study was to explore the difference between isocitrate dehydrogenase (IDH)-1/2 gene mutation-positive and -negative high-grade gliomas (HGGs) using histogram analysis of apparent diffusion coefficient (ADC) and normalized cerebral blood volume (nCBV) maps. We enrolled 52 patients with histopathologi...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-014-1614-z

    authors: Lee S,Choi SH,Ryoo I,Yoon TJ,Kim TM,Lee SH,Park CK,Kim JH,Sohn CH,Park SH,Kim IH

    更新日期:2015-01-01 00:00:00

  • Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.

    abstract:PURPOSE:The purpose of our study was to determine the statistical significance of thresholds of relative cerebral blood volume (rCBV), apparent diffusion coefficient (ADC) and ADC ratios in grading cerebral gliomas. MATERIALS AND METHODS:In this retrospective study, 51 patients with histopathologically confirmed prima...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,收录出版

    doi:10.1007/s11060-009-9807-6

    authors: Arvinda HR,Kesavadas C,Sarma PS,Thomas B,Radhakrishnan VV,Gupta AK,Kapilamoorthy TR,Nair S

    更新日期:2009-08-01 00:00:00

  • Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.

    abstract::Sacral chordoma is a vessel-rich and infiltrative tumor, but the fundamental knowledge of its biological behavior remains unknown. This study was designed to investigate the expression levels and contributions of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) in the angiogenesis and r...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-010-0263-0

    authors: Chen KW,Yang HL,Lu J,Wang GL,Ji YM,Wu GZ,Zhu LF,Liu JY,Chen XQ,Gu YP

    更新日期:2011-02-01 00:00:00

  • Histologic evidence of a radiosensitizing effect of Taxol in patients with astrocytomas.

    abstract::The new anticancer agent Taxol appears to potentiate the effects of radiation on brain tumor cell lines in vitro and was recently evaluated by our group as a radiosensitizer in a phase I study for primary brain tumors. In that study, we administered Taxol as a three-hour IV infusion repeated every week for six weeks a...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1005710710418

    authors: Wehbe T,Glantz M,Choy H,Glantz L,Cortez S,Akerley W 3rd,Mills P,Cole B

    更新日期:1998-09-01 00:00:00

  • Cerebellar anaplastic astrocytoma in a teenager with Ollier Disease.

    abstract:INTRODUCTION:Ollier Disease is a sporadic skeletal disorder with a predisposition to oncogenesis. It is estimated at around 1/100,000. We are presenting a young patient with Ollier Disease and high-grade astrocytoma. CASE REPORT:A 14-year-old, Caucasian male with Ollier Disease presented with a history of headaches, v...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-008-9583-8

    authors: Walid MS,Troup EC

    更新日期:2008-08-01 00:00:00

  • Late causes of death in children treated for CNS malignancies.

    abstract::As the outcome for pediatric central nervous system (CNS) malignancies improves, data regarding long term effects and risk of early mortality are needed. Using the Surveillance, Epidemiology, and End Results database, we evaluated the causes of mortality in 5-year survivors of a CNS tumor diagnosed prior to the age of...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-013-1197-0

    authors: Perkins SM,Fei W,Mitra N,Shinohara ET

    更新日期:2013-10-01 00:00:00

  • Ependymoma in children under the age of 3 years: a report from the Canadian Pediatric Brain Tumour Consortium.

    abstract::The determination of optimal therapy for ependymoma (EP) in infants is ongoing. We describe the incidence, management and outcomes of Canadian infants with EP to discern potential future research questions. Of 579 cases registered in a national database of children <36 months of age diagnosed with a brain tumor from 1...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-014-1396-3

    authors: Purdy E,Johnston DL,Bartels U,Fryer C,Carret AS,Crooks B,Eisenstat DD,Lafay-Cousin L,Larouche V,Wilson B,Zelcer S,Silva M,Bouffet E,Keene D,Strother DR

    更新日期:2014-04-01 00:00:00

  • Surgical resection of fourth ventricular ependymomas: case series and technical nuances.

    abstract::Ependymomas are rare neuroepithelial tumors which may arise anywhere along the ventricular system. Tumors arising in the fourth ventricle present unique challenges. Complete tumor resection favors prolonged survival, but may result in inadvertent injury of surrounding neural structures-such as cranial nerve (CN) nucle...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s11060-016-2198-6

    authors: Winkler EA,Birk H,Safaee M,Yue JK,Burke JF,Viner JA,Pekmezci M,Perry A,Aghi MK,Berger MS,McDermott MW

    更新日期:2016-11-01 00:00:00

  • Modern meningioma imaging techniques.

    abstract::Steady improvements in imaging modalities have enabled a new realm of capabilities in the identification and assessment of meningiomas. The cross-sectional imaging modalities, MRI and CT, have improved in resolution and fidelity. These modalites now provide not only improved structural information but also insights in...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s11060-010-0367-6

    authors: Saloner D,Uzelac A,Hetts S,Martin A,Dillon W

    更新日期:2010-09-01 00:00:00